High Court's Hikma Decision Reshapes 'Skinny Label' Suits
On June 4, the U.S. Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., marking a significant victory for generic drug manufacturers....To view the full article, register now.
Already a subscriber? Click here to view full article